Gem Aromatics Limited · NSE:GEMAROMA
Gem Aromatics — Q2 & H1 FY26 Earnings Presentation
33 slides from Gem Aromatics's earnings presentation, Nov 13, 2025
Slide 1: Submission of Investor Presentation to BSE and NSE
(Formerly Known as Gem Aromatics Pvt. Ltd.) Manufacturer & Exporters of Essential Oils & Aromatics Chemicals Registered Office: A/410-411, A-Wing, Kailash Ind. Complex, Powai Vikhroli link Rd, Vikhroli West, Mumbai-400079. Maharashtra, India, Tel No: +91-2225185231/25185931 CIN: L24246MH1997PLC11105
Slide 2: Investor Presentation Q2 & H1FY26
Investor Presentation Q2 & H1FY26
Slide 3: Disclaimer
Disclaimer This presentation and the accompanying slides (the “Presentation”), has been prepared by Gem Aromatics Ltd (the “Company”), solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the bas
Slide 4: Table of Contents
Table of Contents Company Overview Q2 & H1FY26 Highlights Annual Financials 3
Slide 5: Company Overview
AROMATICS Company Overview 6 GEM
Slide 6: A Journey of 3 Decades leading to Growth and Transformation
~A Journey of 3 Decades leading to Growth and Transformation… 1997 2008 2009 2013 2016 Executed the first Introduced a new Received Star Export Commenced production Incorporated our export order vertical – Clove oil House status at Unit II – Badaun, U.P Company and inaugurated the Silvassa Facility
Slide 7: Established Scale with a Strong Market Presence
…Established Scale with a Strong Market Presence • One of the leading Indian manufacturer of specialty ingredients, including essential oils, aroma chemicals, and value-added derivatives. • Company offers a wide range of products across Mint, Clove, Phenol, and other natural and synthetic ingredient
Slide 8: Mint & Mint Derivative – Well Established Business
Mint & Mint Derivative – Well Established Business • Largest business segment with strong customer demand • Widely used in Oral Care, Pharma, Nutraceuticals, Personal Care, Wellness • With a facility in the Budaun mint belt (UP), we benefit from easy, cost-efficient access to quality mint raw materi
Slide 9: Clove & Clove Derivatives – High-Value Segment with Leadership in Eugenol
Clove & Clove Derivatives – High-Value Segment with Leadership in Eugenol • Second-largest Revenue contributor with Strong Margin Profile • One of the largest processors of Clove Oil and Eugenol (by volume in India, FY25) • Used in Flavor, Dental Care, Pharma, Fragrance Applications Products Growth
Slide 10: Entering Advanced Chemistry with Phenol Derivatives
Entering Advanced Chemistry with Phenol Derivatives • Diversified phenolic portfolio serving pharma, antioxidant and fragrance applications. • Sustainable vapor-phase technology ensures high-purity output with near-zero effluent. • Forward-integrated processes enable entry into limited-competition,
Slide 11: Citral Chemistry (New Products) and Other Natural & Synthetic Ingredients
Citral Chemistry (New Products) and Other Natural & Synthetic Ingredients Natural & Synthetic • Largest processor of Eucalyptus Oil in India with ~58% Citral Chemistry Ingredients market share (FY25)* New Products Entering into High-Value Aroma Molecules • Diversified sourcing of crude eucalyptus &
Slide 12: Focus on Growing Value Added Products – From Base to Advanced Molecules
Focus on Growing Value Added Products – From Base to Advanced Molecules Category Mother Ingredient/ Base Product Advanced / Specialty Products Industry Peppermint Mint & Mint Spearmint Cooling Agents – WS 03, 05 • Oral Care Derivatives Menthol • Cosmetics Clove & Clove Eugenol • Nutraceuticals Clove
Slide 13: Experienced Promoters and Management Team (1/2)
Experienced Promoters and Management Team…(1/2) Promoters and Directors Vipul Parekh Kaksha Vipul Parekh Yash Vipul Parekh Whole-Time Director Whole-Time Director, Chairman and CFO Managing Director and Chief Executive Officer • Associated with the company since inception • Associated with the compa
Slide 14: Experienced Promoters and Management Team (2/2)
Experienced Promoters and Management Team…(2/2) Non-Executive Director & Independent Directors KMP and SMP Dinesh TV Chief Operating Officer • Associated with the company since inception • M.Sc. in Chemistry from University of Calicut • Over 25 years of experience in plant operations and process opt
Slide 15: Strategically located Manufacturing Facilities with Existing Capacity of 5,346 MTPA
Strategically located Manufacturing Facilities with Existing Capacity of 5,346 MTPA Dahej Access to Phenol and Excellent Connectivity via Budaun Expressway and Located in India’s Ports. prime Mint Silvassa Facility Budaun Facility Dahej Facility Cultivation Belt. (1997) (2016) (2024) Capacity Capaci
Slide 16: Fueling Future Growth – Greenfield Project at Dahej with 10,829 MTPA Capacity
Fueling Future Growth – Greenfield Project at Dahej with 10,829 MTPA Capacity Key Plant Highlights Strategic Advantages Krystal Ingredients Pvt. Ltd. Wholly owned subsidiary Expected to Commission in November 2025 ✓ Focus on High Value Specialty Molecules enables Superior Margins and Stronger Market
Slide 17: Dahej Plant Pictures
|| Dahej Plant Pictures 16
Slide 18: From India to the World: Strengthening Our Global Presence
From India to the World: Strengthening Our Global Presence Serving 225 domestic and Germany Moldova 44 international customers Bulgaria United across 18 countries Kingdom USA Ireland Netherlands France China Israel Strategic investor Spain Hong Kong and customer Italy Thailand Uganda Nepal Indonesia
Slide 19: Complex Chemistries Process Technology
With Complex and Advanced End-to-End Processes Journey of a Molecule Raw Material Arrival Extraction & Isolation Complex Chemistry In-Action Automated Quality & Analytics Final Formulation & Packaging Quality checked, tracked, and Botanicals and petrochemicals Breakthrough molecules and derivatives
Slide 20: Strong and Robust R&D Capabilities Driving Innovation
Strong and Robust R&D Capabilities Driving Innovation Structured R&D Focus Areas Existing Product Innovation: Portfolio Expansion: Strategic Market Targeting: ✓ Improving yields, selectivity, and process ✓ New molecules, new chemistry, and step ✓ Identifying high-demand products with limited efficie
Slide 21: Q2 & H1FY26 Highlights
AROMATICS Q2 & H1FY26 Highlights Cie GEM
Slide 22: Management Commentary
Management Commentary Yash Vipul Parekh Managing Director and Chief Executive Officer We got listed on NSE & BSE on 26th August 2025 and this marks a key milestone in our 27- year journey. The IPO was undertaken to strengthen our balance sheet through partial repayment of borrowings, to support our
Slide 23: Financial Performance Impacted by US Tariffs and GST Rate Revision
Financial Performance Impacted by US Tariffs and GST Rate Revision Revenue EBITDA (Rs Cr) & PAT (Rs Cr) & Key Business Update (Rs Cr) Margin (%) Margin (%) USA Tariff Impact 14% 9% • USA levied a 25% tariff on Indian imports on 1 August 2025 and further increased it 112 to 50% on 27 August 2025. 90
Slide 24: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement Consolidated (Rs Cr) Q2FY26 Q2FY25 YoY (%) Q1FY26 QoQ (%) H1FY26 H1FY25 YoY (%) Net Revenue From Operations 89.5 112.2 -20.2% 87.6 2.2% 177.2 204.9 -13.5% Cost of Goods Sold 76.9 87.4 61.8 138.7 157.5 Gross Profit 12.6 24.8 -49.3% 25.9 -51.4% 38.5 47.4 -18.8% Gro
Slide 25: Consolidated Balance Sheet
Consolidated Balance Sheet Liabilities (Rs Cr) Mar-25 Sept-25 Assets (Rs Cr) Mar-25 Sept-25 Property, Plant & Equipment and Share Capital 9.4 10.4 43.4 206.2 Intangible Assets Reserves & Surplus 274.6 444.8 Capital Works-in-progress 125.5 25.1 Shareholders' Funds 284.0 455.2 Right To Use Assets 11.0
Slide 26: Annual Financials
Annual Financials AROMATICS
Slide 27: Key Financial and Operating Metrics (1/2)
Key Financial and Operating Metrics (1/2) Revenue from Operations (Rs Cr) EBITDA (Rs Cr) & Margin (%) PAT (Rs Cr) & Margin (%) 504 17.0% 18.0% 453 16.0% 11% 11% 11% 425 89 78 50.1 53.4 66 44.7 FY23 FY24 FY25 FY23 FY24 FY25 FY23 FY24 FY25 EBITDA EBITDA Margin PAT PAT Margin Debt (Rs Cr) Capex (Rs Cr)
Slide 28: Key Financial and Operating Metrics (2/2)
Key Financial and Operating Metrics (2/2) No. of Countries Present In Number of Customers 308 18 246 269 51 44 17 47 16 257 225 199 FY23 FY24 FY25 FY23 FY24 FY25 Domestic International Total Contribution from Top 10 Customers (%) Repeat Customers Revenue (%) 87 94 77 66 52 56 FY23 FY24 FY25 FY23 FY2
Slide 29: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement Consolidated (Rs Cr) FY23 FY24 FY25 CAGR Net Revenue From Operations 424.8 452.5 504.0 8.9% Cost Of Goods Sold 317.4 341.2 375.9 Gross Profit 107.4 111.3 128.0 9.2% Gross Profit Margin (%) 25.3% 24.6% 25.4% Employee Expenses 10.8 11.1 12.8 Other Expenses 30.4 21.
Slide 30: Consolidated Balance Sheet
Consolidated Balance Sheet Liabilities (Rs Cr) Mar-23 Mar-24 Mar-25 Sept-25 Assets (Rs Cr) Mar-23 Mar-24 Mar-25 Sept-25 Property, Plant & Equipment Share Capital 1.8 9.4 9.4 10.4 26.4 40.3 43.4 206.2 and Intangible Assets Reserves & Surplus 177.7 221.2 274.6 444.8 Capital Works-in-Progress 10.9 30.4
Slide 31: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement Particulars (Rs Cr) FY23 FY24 FY25 H1FY26 Net Profit Before Tax and Extraordinary Items 56.1 67.6 74.7 8.3 Adjustments for: Non-Cash Items / Other Investment or 15.8 10.4 15.3 15.0 Financial Items Operating Profit Before Working Capital Changes 71.9 78.0 90.0 23.3 Ch
Slide 32: Shareholding Pattern
Shareholding Pattern Capital Market Information (as on 13th November 2025) Shareholding Pattern (as on 30th September 2025) BSE/NSE Code 544491/ GEMAROMA Public Promoters 36.4% 55.1% CMP (Rs) 199.5 Market Cap (Rs Cr) 1,042 Shares (Cr) 5.22 DII's 6.6% FII's Face Value (Rs) 2 2.0% 31
Slide 33: Thank You
Thank You Gem Aromatics Ltd Stellar IR Advisors Pvt. Ltd. CIN No. L24246MH1997PLC111057 Akshita Gohil Akhilesh Gandhi, CFA | akhilesh@stellar-ir.com secretarial@gemaromatics.in Omkar Sawant| omkar@stellar-ir.com Phone: 9322121990 | 022 25185231 Phone: 022 62398024 www.gemaromatics.com www.stellar-ir